We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kyowa Kirin

News List

Kyowa Kirin Receives Partial Change Approval for ORKEDIA in Japan firstwordpharma
December 22, 2019
The approval is based on the result of the Phase 3 clinical trial that evaluates the efficacy of ORKEDIA for hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism who are unable to undergo parathyroidectomy or relapse after p
Kyowa Kirin gets FDA nod for Parkinson’s drug biospectrumasia
September 04, 2019
Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease
Kyowa Kirin buys back Tivozanib rights from AVEO oncology biospectrumasia
August 04, 2019
Kyowa Kirin will reobtain the non-oncology rights of tivozanib in AVEO territories excluding the rights which are currently sublicensed to EUSA Pharma
EU approves Kyowa Kirin’s drug for rare lymphoma pharmaphorum
November 30, 2018
The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma.

Previous page 1 2 Next page